Equillium Inc
NASDAQ:EQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
McCormick & Company Inc
NYSE:MKC.V
|
US |
|
Gansu Jingyuan Coal Industry and Electricity Power Co Ltd
SZSE:000552
|
CN |
During the last 3 months Equillium Inc insiders have not bought any shares, and sold 1.1m USD worth of shares. The stock price has increased by 72% over this period (open performance analysis).
The last transaction was made on
Mar 13, 2026
by
Zedelmayer Christine
, who
sold
300.8k USD
worth of 
EQ shares.
During the last 3 months Equillium Inc insiders have not bought any shares, and sold 1.1m USD worth of shares. The stock price has increased by 72% over this period (open performance analysis).
The last transaction was made on
Mar 13, 2026
by
Zedelmayer Christine
, who
sold
300.8k USD
worth of EQ shares.
Equillium Inc
Glance View
Equillium, Inc. engages in the development of products for severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. The company is headquartered in La Jolla, California and currently employs 45 full-time employees. The company went IPO on 2018-10-12. The firm develops products to treat severe autoimmune and inflammatory disorders with unmet medical needs. The firm's initial product candidate, itolizumab (EQ001), is a clinical-stage, monoclonal antibody that selectively targets CD6, a co-stimulatory receptor differentially expressed on subsets of pro-inflammatory T cells. The firm's CD6 plays a central role in the modulation of effector T cell, or Teff cell, activity and trafficking. Activated Teff cells drive several immuno-inflammatory diseases across therapeutic areas including transplant science, systemic autoimmunity, pulmonary, neurologic, gastrointestinal, renal, vascular, ophthalmic and dermatologic disorders. The company also provides structured-domain peptides, including BNZ-1 and BNZ-2, entirely in-house from product discovery platform. These lead product candidates are multi-specific inhibitors that targets range of immuno-inflammatory indication.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
